Calif. Gov. Gavin Newsom unveils homelessness plan to clear street camps
Calif. Gov. Gavin Newsom unveils homelessness plan to clear street camps
Show Caption
Hide Caption
Gavin Newsom says California has world's 4th largest economy
California was officially named the world's fourth-largest economy, according to the International Monetary Fund and the US Bureau of Economic Analysis.
unbranded - Newsworthy
California Gov. Gavin Newsom unveiled a wide-reaching plan to tackle the state's severe homelessness crisis that would direct hundreds of cities, towns and counties to effectively ban tent camping on sidewalks and parks, according to a statement released early Monday, May 12.
"The Governor is calling on every local government to adopt and implement local policies without delay," the statement says.
The move comes as the state prepares for a surge of funding for homelessness and mental health after voters approved a multi-billion-dollar bond measure in November, and after a landmark U.S. Supreme Court ruling in 2024 that opened the door to arresting and fining individuals for sleeping in public spaces.
More: California failed to track how billions are spent to combat homelessness programs, audit finds
The model ordinance is not a flat directive, giving local municipalities a guideline and an effective choice to implement the policies. The template will be provided to every community as a "starting point," the statement says, so jurisdictions can tailor it.
California is the nation's most populous state and is home to a significant portion of the country's homeless individuals. Nearly a quarter of all unhoused Americans live in California, according to federal data and local studies.
The two-term governor will join California Department of Health and Human Services Secretary Kim Johnson, the Director of the California Department of Health Care Services Michelle Baass and unnamed mental health leaders at 1 p.m. PT, according to a news release.
More: The homeless population is increasing. Will Trump's second term make it worse?
The event, which will be livestreamed across the governor's social media pages, is an "announcement regarding his administration's continued transformation of behavioral health services supporting California's seriously ill and homeless populations," the release says.
"There's nothing compassionate about letting people die on the streets," Newsom said in the statement. "Local leaders asked for resources — we delivered the largest state investment in history. They asked for legal clarity — the courts delivered. Now, we're giving them a model they can put to work immediately, with urgency and with humanity, to resolve encampments and connect people to shelter, housing, and care."
Kathryn Palmer is a trending news reporter for USA TODAY. You can reach her at kapalmer@usatoday.com and on X @KathrynPlmr.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
20 minutes ago
- Miami Herald
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older CAMBRIDGE, MA / ACCESS Newswire / June 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive results from a Phase 3 efficacy study (P304) evaluating the relative vaccine efficacy (rVE) against influenza illness of mRNA-1010, the Company's seasonal influenza (flu) vaccine candidate, compared to a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older. mRNA-1010 achieved the most stringent superiority criterion prespecified in the protocol, with an rVE of 26.6% (95% CI; 16.7%, 35.4%) in the overall study population. Additionally, strong rVE was observed for each influenza strain contained in the vaccine, including A/H1N1 (rVE=29.6%), A/H3N2 (rVE=22.2%), and the B/Victoria lineages (rVE=29.1%). Subgroup analyses confirmed a consistently strong rVE point estimate across age groups, risk factors and previous influenza vaccination status. In participants aged 65 years and older, mRNA-1010 demonstrated an rVE of 27.4%. "Today's strong Phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in older adults. The severity of this past flu season underscores the need for more effective vaccines," said Stéphane Bancel, Chief Executive Officer of Moderna. "An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines." In a previous Phase 3 study, mRNA-1010 had already demonstrated superior seroconversion rates and geometric mean titer ratios (GMR) against all strains included in the vaccine compared to both high-dose and standard-dose licensed seasonal influenza vaccine. [1] According to the CDC, seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-2025 season. [2] More than 600,000 Americans were hospitalized due to flu-related illness last year, leading to substantial direct and indirect costs, as well as widespread disruption to daily life and work. [3] P304 ( NCT06602024 ) is a Phase 3, randomized, observer-blind, active-controlled, case-driven, pivotal efficacy, immunogenicity and safety study. The trial enrolled 40,805 adults aged 50 years and older across 11 countries. Participants were randomly assigned to receive either a single dose of mRNA-1010 or a standard-dose licensed comparator, with a median follow-up of six months. Safety and tolerability of mRNA-1010 were consistent with reported results from a previous Phase 3 study. [4] The majority of solicited adverse reactions (SARs) were mild. Injection site pain was the most common local SAR, and fatigue, headache and myalgia were the most common systemic SARs reported. There were no significant differences between the groups in the rates of unsolicited adverse events, serious adverse events, or adverse events of special interest. Moderna plans to present these data at an upcoming medical conference and submit for peer-reviewed publication. The Company will engage with regulators on filing submissions for mRNA-1010. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna's engagement with regulators on filing submissions for its standalone flu vaccine candidate; and the efficacy, safety and tolerability of mRNA-1010. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading "Risk Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at . Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date of this press release. Moderna Contacts Media: Chris RidleyHead of Global Media Relations+1 Investors: Lavina TalukdarSenior Vice President & Head of Investor Relations+1 SOURCE: Moderna, Inc.
Axios
22 minutes ago
- Axios
Trump tariffs could dampen July Fourth fireworks for 2026
As Americans prepare to light up the skies this Fourth of July, the fireworks industry is sounding the alarm: without tariff relief, the nation's 250th birthday celebration in 2026 could be in jeopardy. Why it matters: A looming tariff burden on Chinese imports is sparking fears of higher costs, supply shortages and even canceled shows. "If the tariff increases again back up to triple digits — let's say 145% — it will cripple this industry," Julie Heckman, executive director of the American Pyrotechnics Association, told Axios. The big picture: 99% of consumer fireworks and 90% of professional display fireworks used in the U.S. come from China, Heckman said. A 25% to 145% tariff imposed under a trade provision known as Section 301 is adding strain to the supply chain and pricing. China typically halts fireworks production during hot summer months due to safety risks, narrowing the window for U.S. importers to place and receive orders. Zoom in: Bruce Zoldan, CEO of Ohio-based Phantom Fireworks, told Axios that his 100 stores have seen a big surge in recent days. Over the weekend, Phantom also opened 1,600 seasonal stands and tents. "People are starting to buy now," he said, noting sales are almost 30% higher per day than last year. "If you wait until July 1st, 2nd, or 3rd, half the merchandise is sold out and the lines are long." Phantom — the nation's largest consumer-based retail fireworks company, supplying thousands of stores nationwide like Home Depot — received 85% of its inventory prior to tariffs, Zoldan said. "There could be a few minor changes, but for the most part, our prices are stable with the last year," he said. "Now, going into next year that's another story." State of play: Industry leaders say they need an exemption like the one President Trump granted in 2019 to move forward with planning for 2026 and beyond. "Thirty percent is not sustainable — not going into what we think will be the biggest celebration, consumption of fireworks ever on record," Heckman told Axios. "This isn't political for us," Heckman said. "We support the president 100%, and themajority of firework entities and their customers — the folks coming in to celebrate Independence Day — they are his base." The other side: The White House pushed back on the fireworks industry's plea for tariff relief. "Real prosperity and patriotism isn't celebrating the independence of our country with cheap foreign-made firecrackers and trinkets," White House spokesman Kush Desai said in a statement to Axios. "It's having a country with booming Main Streets, a thriving working class, and robust manufacturing." Yes, but: Heckman said moving fireworks production stateside is impossible, especially for 2026. "Even if we brought some manufacturing back to the U.S., it wouldn't be optimal," Heckman said, noting it's highly dangerous, labor-intensive and regulated. "We could never produce the volume the U.S. relies on for celebrating Independence Day." What's next: Heckman said her organization has been advocating on Capitol Hill and has a meeting in late July with the U.S. Trade Representative's office. "Right now, we're at a standstill," Zoldan said of the fireworks industry. "We're getting close to the point where we have to place our orders for next year, and they have to start manufacturing right after Labor Day." Zoldan said any delay past Labor Day for submitting orders means a certain percentage won't be manufactured in time to get to America.
San Francisco Chronicle
27 minutes ago
- San Francisco Chronicle
EPA employees put names to 'declaration of dissent' over agency moves under Trump
A group of Environmental Protection Agency employees on Monday published a declaration of dissent from the agency's policies under the Trump administration, saying they 'undermine the EPA mission of protecting human health and the environment.' More than 170 EPA employees put their names to the document, with about 100 more signing anonymously out of fear of retaliation, according to Jeremy Berg, a former editor-in-chief of Science magazine who is not an EPA employee but was among non-EPA scientists or academics to also sign. The latter figure includes over 70 Nobel laureates. The letter represents rare public criticism from agency employees who could face blowback for speaking out against a weakening of funding and federal support for climate, environmental and health science. Scientists at the National Institutes of Health made a similar move earlier in June. "Since the Agency's founding in 1970, EPA has accomplished (its) mission by leveraging science, funding, and expert staff in service to the American people. Today, we stand together in dissent against the current administration's focus on harmful deregulation, mischaracterization of previous EPA actions, and disregard for scientific expertise," the letter read. Agency spokespeople did not immediately respond Monday to messages seeking comment. Employees want the EPA get back to its mission 'I'm really sad. This agency, that was a superhero for me in my youth, we're not living up to our ideals under this administration. And I really want us to,' said Amelia Hertzberg, an environmental protection specialist at the EPA who has been on administrative leave since February from the Office of Environmental Justice and External Civil Rights, while the administration works to close down her department. Hertzberg's work focused on the most vulnerable groups impacted by pollution: pregnant and nursing people, young children and babies, the elderly, people with preexisting and chronic health conditions and people living in communities exposed to higher levels of pollution. That wasn't supposed to be controversial, but it's become so in this political climate, she said. 'Americans should be able to drink their water and breathe their air without being poisoned. And if they aren't, then our government is failing,' she said. Berg, who also directed the National Institute of General Medical Sciences at NIH from 2003-2011, said the dissent isn't motivated by partisan criticism. He said the employees hope it will help the EPA get back to the mission for which it was established — which 'only matters if you breathe air and drink water." The letter outlines what the EPA employees see as five main concerns: undermining public trust; ignoring scientific consensus to benefit polluters; reversing EPA's progress in America's most vulnerable communities; dismantling the Office of Research and Development; and promoting a culture of fear, forcing staff to choose between their livelihood and well-being. EPA has cut funding and rolled back federal regulations Under Administrator Lee Zeldin, EPA has cut funding for environmental improvements in minority communities, vowed to roll back federal regulations that lower air pollution in national parks and tribal reservations, wants to undo a ban on a type of asbestos and proposed repealing rules that limit planet-warming greenhouse gas emissions from power plants fueled by coal and natural gas. Zeldin began reorganizing the EPA's research and development office as part of his push to slash their budget and gut their study of climate change and environmental justice. And he's seeking to roll back pollution rules that an Associated Press examination found were estimated to save 30,000 lives and $275 billion every year. 'People are going to die,' said Carol Greider, a Nobel laureate and professor of molecular and cellular biology at the University of California, Santa Cruz, who also signed the letter. She described last week's East Coast heat wave as evidence of the ways people are feeling the effects of climate change. 'And if we don't have scientists at the EPA to understand how what we do that goes into the air affects our health, more people are going to die,' she added. Berg said the declarations of dissent from both the NIH and EPA employees are noteworthy because they represent scientists speaking out as their careers are on the line. Even non-agency employees have to consider whether the government will withdraw research funding. Greider, asked about fears of repercussions or retaliation, said she's 'living the repercussions of everything.' She regularly meets with graduate students who are worried about pursuing scientific careers as labs lose funding. It's a long-term problem if we aren't supporting the next generation of scientists, she said: "That's decades worth of loss.' ___ ___
